ライフサイエンスコーパス: social phobia

1 egorical diagnoses (e.g., panic disorder and social phobia).

2 sorder, premenstrual dysphoric disorder, and social phobia.

3 he effects of SSRI treatment for generalized social phobia.

4 ly has an impact on risk for agoraphobia and social phobia.

5 specifically referred for an evaluation for social phobia.

6 about specific functional impairment due to social phobia.

7 eek, open trial of nine patients with DSM-IV social phobia.

8 pharmacologic management of serious forms of social phobia.

9 bsessive-compulsive disorder, depression, or social phobia.

10 erapy may have efficacy for the treatment of social phobia.

11 oximated those of established treatments for social phobia.

12 tive treatment for patients with generalized social phobia.

13 ine oxidase inhibitor phenelzine sulfate for social phobia.

14 er in relatives of probands with generalized social phobia.

15 or depression, alcohol abuse/dependence, and social phobia.

16 ng the families of probands with generalized social phobia.

17 relatives of 24 comparison subjects without social phobia.

18 earlier finding of a familial liability for social phobia.

19 among relatives of probands with generalized social phobia.

20 for simple phobia, and 13.3% (and 4.5%) for social phobia.

21 ttern of striatal activation may manifest in social phobia.

22 ildhood behavioral inhibition and adolescent social phobia.

23 rage longitudinal fMRI studies of adolescent social phobia.

24 face processing also manifest in adolescent social phobia.

25 fferentially affects response in generalized social phobia.

26 social stimuli more generally in generalized social phobia.

27 disorder, generalized anxiety disorder, and social phobia.

28 chiatric disorders, including depression and social phobia.

29 (31%), agoraphobia or panic disorder (22%), social phobia (17%), and specific phobia (15%).

30 ed in 58 medication-free adolescents-14 with social phobia, 18 with generalized anxiety disorder but

31 ared in 39 medication-free participants with social phobia (25 adults and 14 adolescents) and 39 heal

32 imple (3.3% vs. 11.5%, Z=-3.13, p<0.001) and social phobias (3.9% vs. 9.7%, Z=2.38, p<0.05) were sign

33 isorder (9.3%), specific phobias (8.8%), and social phobia (6.6%).

34 Among those with DSM-IV social phobia (7.2%), classification based on number (no

35 6.7% for panic disorder, 12.6% vs. 25.3% for social phobia, 9.1% vs. 25.9% for alcohol abuse or depen

36 is also associated with risk for adolescent social phobia, a similar pattern of striatal activation

37 ic and environmental risk for three phobias (social phobia, agoraphobia, and animal phobia) in twins

38 confirm earlier findings of a higher rate of social phobia among relatives of probands with generaliz

39 Sixteen patients with generalized social phobia and 16 healthy comparison subjects group-m

40 ee relatives of 23 patients with generalized social phobia and 74 first-degree relatives of 24 compar

41 d these indices for persons with and without social phobia and adjusted where indicated for the effec

42 All of the genetic risk factors for social phobia and agoraphobia were shared with those tha

43 e and negative between extraversion and both social phobia and agoraphobia, and that between extraver

44 gh and positive between neuroticism and both social phobia and agoraphobia, and that between neurotic

45 ccount entirely for the genetic liability to social phobia and agoraphobia, but not animal phobia.

46 a greater-than-expected association between social phobia and alcohol use disorders.

47 Relative risks for generalized social phobia and avoidant personality disorder were mar

48 with social phobia, depression, or comorbid social phobia and depression.

49 ial phobia, depressive disorder, or comorbid social phobia and depressive disorder and 44 healthy com

50 among relatives of probands with generalized social phobia and extend these findings by specifically

51 esponse to facial expressions in generalized social phobia and generalized anxiety disorder.

52 circuitry dysfunctions differ in generalized social phobia and generalized anxiety disorder.

53 receptor binding potential in patients with social phobia and healthy comparison subjects.

54 vely assessed among individuals with DSM-III social phobia and individuals with subclinical social ph

55 differences in favor of CBT for measures of social phobia and interpersonal problems, but not for de

56 in 10 unmedicated subjects with generalized social phobia and no significant lifetime psychiatric co

57 In contrast, relative risks for discrete social phobia and nongeneralized social phobia were not

58 d in patients with anxiety disorders such as social phobia and posttraumatic stress disorder (PTSD).

59 ove our understanding of the relationship of social phobia and risk for alcohol conditions, which may

60 ession was used to assess the association of social phobia and subclinical social phobia with inciden

61 in individuals, between either depression or social phobia and the broad autism phenotype.

62 18 with generalized anxiety disorder but not social phobia, and 26 with no psychiatric disorder-match

63 ion in healthy adolescents, adolescents with social phobia, and adolescents with generalized anxiety

64 inson's disease therapy, ataxia, depression, social phobia, and behaviour disturbances following brai

65 ts, psychiatric comorbidity (panic disorder, social phobia, and drug dependence), disability and rest

66 iety disorders, panic disorder, agoraphobia, social phobia, and obsessive-compulsive disorder.

67 ty of life for patients with panic disorder, social phobia, and posttraumatic stress disorder.

68 mined hemispheric asymmetries of function in social phobia, and the influence of comorbidity with dep

69 ersonal relationships; these include autism, social phobia, and the personality disorders.

70 isorder independently predicted new onset of social phobia, and the two interacted to predict new ons

71 anic disorder, generalized anxiety disorder, social phobia, and/or posttraumatic stress disorder (wit

72 xiety disorder, panic disorder, agoraphobia, social phobia, animal phobia, and situational phobia) we

73 xiety disorder, panic disorder, agoraphobia, social phobia, animal phobia, situational phobia, and ne

74 e, panic, or posttraumatic stress disorders; social phobia; anxious or melancholic features; or more

75 Most comorbid simple and social phobias are temporally primary, while most comorb

76 Several anxiety disorders, including social phobia, are genetically influenced.

77 to what extent indices were attributable to social phobia as opposed to comorbid major depression.

78 e 33 individuals with a DSM-III diagnosis of social phobia at baseline, only one developed heavy drin

79 e of specificity in the course of simple and social phobia but less specificity in the course of othe

80 e course of generalized anxiety disorder and social phobia but not panic disorder, suggesting that Pe

81 d be higher rates of the generalized type of social phobia--but not the nongeneralized (or "discrete"

82 Social phobia can be a serious, disabling anxiety disord

83 rbid with other DSM-III-R disorders than was social phobia characterized by other social fears.

84 pidemiologic data on the distinction between social phobia characterized by pure speaking fears and t

85 However, the social phobia characterized by pure speaking fears was l

86 alized cognitive processing in patients with social phobia, depression, or comorbid social phobia and

87 A total of 125 unmedicated patients with social phobia, depressive disorder, or comorbid social p

88 The neural correlates of adult social phobia during face processing also manifest in ad

89 rmine whether the neural correlates of adult social phobia during face processing also manifest in ad

90 stic Interview-Version 2.1 module for DSM-IV social phobia, enhanced with 6 additional (for a total o

91 hobia, predominantly concurrent (same year); social phobia, equal proportions primary and concurrent;

92 nic disorder (PD), and phobias (agoraphobia, social phobia, etc.).

93 One-third of the people with lifetime social phobia exclusively reported speaking fears, while

94 Evidence for linkage to social phobia for chromosome 16 markers was identified.

95 anic disorder, agoraphobia, specific phobia, social phobia, generalized anxiety disorder, posttraumat

96 cluded 57 probands with an anxiety disorder (social phobia, generalized anxiety disorder, separation

97 Within the social phobia group, there was a nonsignificant correlat

98 sponse relative to the healthy comparison or social phobia group.

99 Generalized social phobia (GSP) and generalized anxiety disorder (GA

100 Generalized social phobia (GSP) is characterized by fear of social i

101 Generalized social phobia (GSP) is characterized by fear/avoidance o

102 Generalized social phobia (gSP), also known as generalized social an

103 ng of social anxiety disorder (also known as social phobia) has moved from rudimentary awareness that

104 consequences, comorbid conduct disorder and social phobia, higher interpersonal dependency and lower

105 Patients with generalized social phobia, however, showed significantly increased r

106 nge of functional impairment attributable to social phobia in a community sample, and (2) to verify t

107 While social phobia in adolescence predicts the illness in adu

108 as directly compared the neural responses in social phobia in adults and adolescents.

109 Social phobia in clinical studies is vividly associated

110 portrayal of the impairment associated with social phobia in community samples.

111 and difficulty experienced by patients with social phobia in social situations.

112 Rather, social phobia in the community seems to exist on a conti

113 aroxetine treatment at weeks 1 and 2 for the Social Phobia Inventory (P < .05 for all).

114 12 on the Liebowitz Social Anxiety Scale and Social Phobia Inventory and at week 2 and weeks 6 throug

115 n the Liebowitz Social Anxiety Scale and the Social Phobia Inventory scores were compared across the

116 al Global Impression-Severity of Illness and Social Phobia Inventory scores.

117 mpression-Severity of Illness scale, and the Social Phobia Inventory, and at weeks 4 through 12 for r

118 , Panic Disorder Severity-Self-report Scale, Social Phobia Inventory, and PTSD Checklist-Civilian Ver

119 symptoms: the Brief Social Phobia Scale, the Social Phobia Inventory, and the Liebowitz Social Anxiet

120 Generalized social phobia involves fear/avoidance, specifically of s

121 cial phobia and individuals with subclinical social phobia (irrational fear of social situations with

122 Social phobia is a common, sometimes disabling, fear of

123 The results support the hypothesis that social phobia is associated with dysfunction of left hem

124 Social phobia is associated with substantial impairment

125 Generalized social phobia is common, persistent, and disabling and i

126 Impairment in social phobia is substantial, even in the absence of com

127 ocial anxiety disorder (SAD) (also known as "social phobia") is frequently comorbid with major depres

128 d risk of current panic disorder, dysthymia, social phobia, major depression, and generalized anxiety

129 der, was associated with increased risks for social phobia, major depression, disruptive behavior dis

130 iety disorder, generalized anxiety disorder, social phobia, major depression, dysthymic disorder, and

131 Generalized social phobia may be associated with low binding of [(12

132 Neural correlates that are observed in adult social phobia may represent the persistence of profiles

133 Treatment-seeking individuals with social phobia (N = 40) were asked to give two impromptu

134 -compulsive disorder (OCD) (N=277 [41%]) and social phobia (N=134 [20%]).

135 , generalized anxiety disorder, agoraphobia, social phobia, obsessive-compulsive disorder, anorexia,

136 Social anxiety disorder (social phobia or avoidant disorder) was significantly mo

137 nd to placebo than patients with generalized social phobia or panic disorder.

138 neralized anxiety disorder, agoraphobia, and social phobia or panic) diagnosed according to the Natio

139 ce was 2.30, relative to respondents without social phobia or subclinical social fears.

140 c disorder (OR, 1.3; 95% CI, 1.06-1.59), and social phobia (OR, 1.3; 95% CI, 1.09-1.64).

141 th DSM-IV anxiety disorders (panic disorder, social phobia, or obsessive-compulsive disorder) and to

142 patients with obsessive-compulsive disorder, social phobia, or panic disorder who received placebo in

143 patients with generalized anxiety disorder, social phobia, or panic disorder.

144 ety disorders (generalized anxiety disorder, social phobia, panic disorder, and posttraumatic stress

145 these regions, both the adolescent and adult social phobia patients showed significantly increased BO

146 eptualized) in patients with panic disorder, social phobia, posttraumatic stress disorder, generalize

147 two factorial design in which one factor was social phobia (present versus absent) and the second fac

148 orted on symptoms of generalized anxiety and social phobia prior to participating in a neuroimaging v

149 , fluvoxamine was superior to placebo on all social phobia rating scales at week 8 and beyond.

150 creasing magnitudes characterizes adolescent social phobia, relative to activation in this region in

151 isorder remission, a 39% lower likelihood of social phobia remission, and no difference in likelihood

152 nt PersD predicted a 41% lower likelihood of social phobia remission.

153 bilaterally, reflecting elevated generalized social phobia responses in these regions to all event ty

154 and physiological candidate for influencing social phobia risk.

155 On the Brief Social Phobia Scale, all active treatments were superior

156 scales for social phobia symptoms: the Brief Social Phobia Scale, the Social Phobia Inventory, and th

157 es of increasing magnitude, adolescents with social phobia showed increasingly heightened caudate and

158 The generalized type of social phobia (social anxiety disorder) is a severe and

159 efficacy of fluvoxamine for the treatment of social phobia (social anxiety disorder).

160 xiety disorder, separation anxiety disorder, social phobia, specific phobia, agoraphobia, and obsessi

161 xiety disorder, separation anxiety disorder, social phobia, specific phobia, agoraphobia, and obsessi

162 the participants reported the onset of OCD, social phobia, specific phobia, and generalized anxiety

163 ve disorder, post-traumatic stress disorder, social phobia, specific phobias and generalized anxiety

164 cortex in the pathophysiology of generalized social phobia, specifically through its involvement in d

165 raction fears is needed to determine whether social phobia subtypes can be refined and whether the su

166 The authors examined rates of three social phobia subtypes defined a priori--discrete, nonge

167 y sample, and (2) to verify the existence of social phobia subtypes in the community, and report on t

168 21); this association broadened to panic and social phobia symptoms in adolescence (r = 0.17-0.24 and

169 ly all clinician ratings and self-ratings of social phobia symptoms significantly improved.

170 over 40 min) and placebo (normal saline) on social phobia symptoms.

171 ted as much or very much improved on overall social phobia symptoms.

172 anges on three specialized rating scales for social phobia symptoms: the Brief Social Phobia Scale, t

173 egree relatives of probands with generalized social phobia than among first-degree relatives of compa

174 was significantly lower in the subjects with social phobia than in the comparison subjects.

175 igher rates of major depressive disorder and social phobia than the parents of the Down's syndrome pr

176 uals have high rates of major depression and social phobia that are not associated with the broad aut

177 84 individuals with a history of subclinical social phobia, the cumulative incidence rates of heavy d

178 tion, and psychiatric disorders ranging from social phobia to autism.

179 l expressions in adults and adolescents with social phobia to determine whether the neural correlates

180 gnificantly more likely than persons without social phobia to rate themselves as "low functioning" on

181 y disorder, generalized anxiety disorder, or social phobia to receive 14 sessions of cognitive behavi

182 drinking among respondents with subclinical social phobia was 2.41, and the estimated relative risk

183 Social phobia was assessed with a revised version of the

184 Social phobia was intermediate in that it was influenced

185 In addition, the severity of social phobia was significantly correlated with the enha

186 ibitors (SSRIs) in patients with generalized social phobia was tested.

187 Identifying loci for social phobia was the goal of this study.

188 nparametric (Zlr score) linkage analyses for social phobia were completed with Allegro and Genehunter

189 Persons with social phobia were impaired on a broad spectrum of measu

190 or discrete social phobia and nongeneralized social phobia were not significantly different between t

191 ers, Fourth Edition criteria for generalized social phobia were randomized (and 183 returned for at l

192 s meeting a primary diagnosis of generalized social phobia were recruited via advertisement.

193 , placebo-controlled trial, 92 patients with social phobia were treated with the selective serotonin

194 nd syllables, compared with subjects without social phobia, whereas no difference between groups was

195 bout the neural underpinnings of generalized social phobia, which is defined by a persistent heighten

196 Subjects were 14 patients with generalized social phobia who were less than "very much improved" on

197 association of social phobia and subclinical social phobia with incident alcohol abuse/dependence and

198 In the meantime, people who have social phobia with multiple fears, some of which are non

199 Patients with social phobia with or without a comorbid depressive diso

200 ched on age, IQ, and gender with generalized social phobia without generalized anxiety disorder (N=17

201 The patients with generalized social phobia without generalized anxiety disorder showe

202 eported anxiety in patients with generalized social phobia without generalized anxiety disorder.